Case Studies
Anonymized regulatory outcomes—built on chemical identity clarity.
One representative engagement showing how ChemNames reduces uncertainty in substance identity, inventory status, and documentation—supporting confident TSCA and global compliance decisions.
How we work
A repeatable method for complex substance identity questions.
Every case study below follows the same disciplined approach: define the regulatory question, validate identity evidence, align nomenclature across systems, and document a defensible rationale.
1) Scope the decision point
Clarify the regulatory trigger (e.g., TSCA inventory status, PMN applicability, CDR reporting) and the identity elements that drive it.
2) Verify identity evidence
Assess composition, manufacturing process, analytical data, and naming conventions to determine what can be supported and what must be resolved.
3) Harmonize nomenclature
Map names and identifiers across internal systems and external inventories to reduce ambiguity and prevent downstream inconsistencies.
4) Deliver documentation
Provide a clear, audit-ready narrative and supporting artifacts that enable internal sign-off and regulatory submissions.
Case Study 01
TSCA inventory research & identity verification for a complex substance
Resolved naming ambiguity to support a defensible inventory status determination and internal decision-making.
Client
Client: Anonymized U.S. chemical manufacturer
Industry
Industry: Specialty chemicals
Services
Services: TSCA inventory research, identity verification, documentation support
Year
Year: 2024
Challenge
A substance used across multiple product lines was referenced by inconsistent internal names and supplier descriptors. The team needed a clear, defensible determination of TSCA inventory status and a documented identity rationale suitable for internal review and downstream compliance activities.
Approach
ChemNames reviewed available identity evidence (composition and process descriptors, analytical summaries, and existing identifiers), reconciled naming across internal systems, and performed targeted TSCA inventory research to align the substance identity with the most supportable nomenclature. Deliverables included an audit-ready rationale and a practical naming convention for ongoing use.
Results
Reduced ambiguity
Single, consistent identity narrative adopted across teams
Faster decisions
Clear inventory status pathway for regulatory sign-off
Audit-ready
Documentation structured for internal and external review